Abstract
Objective
To evaluate the protective effect of Kalpaamruthaa (KA), a modified Siddha preparation, in BCR-ABL+ leukemic mouse model.
Methods
BCR-ABL leukemia was induced in 6–10-week-old female BALB/c mice by a single tail vein injection of the 12B1 cell line. Leukemia-induced animals were treated with KA at a dosage of 200 mg/kg body weight dissolved in 0.5 mL of olive oil for 14 days by gastrogavage. Imatinib mesylate was used as the control drug. Glycolytic, gluconeogenic, mitochondrial, tricarboxylic acid cycle and respiratory chain enzymes in the spleen and liver of mouse were compared between the control and experiment groups by biochemical assays.
Results
Leukemia-bearing mice showed a significant increase in glycolytic enzymes and a signififi cant decrease in gluconeogenic enzymes, tricarboxylic acid cycle and respiratory chain enzymes as compared with control animals. Treatment with KA signififi cantly reversed the changes seen in the levels of the glycolytic enzymes, gluconeogenic enzymes and mitochondrial enzymes.
Conclusion
The presence of various flfl avonoids and polyphenols in the drug KA might have resulted in the amelioration of altered glucose metabolism resulting in the regression of leukemia.
Similar content being viewed by others
References
Diamond J, Goldman JM, Melo JV. BCR-ABL, ABLBCR, BCR and ABL genes are all expressed in individual granulocyte-macrophage colony forming unit colonies derived from blood of patients with chronic myeloid leukemia. Blood 1995;85:2171.
Gishizky ML, Johnson-White J, Witte ON. Efficient transplantation of BCR/ABL-induced chronic myelogenous leukemia-like syndrome in mice. USA: Proceedings of the National Academy of Science; 1993;90:3755.
National Cancer Registry Programme. Two year report of the population based cancer registries 1999-2000. New Delhi: Indian Council of Medical Research; 2005.
Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer 2011;11:85–95.
Teicher BA, Linehan WM, Helman LJ. Targeting cancer metabolism. Clin Cancer Res 2012;18:5537–5545.
Druker BJ, Guilhot F, O'Brien SG, Gathmann MScI, Kantarjian H, Gattermann N, et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 2006;355:2408–2417.
Chakraborty JB, Mahato SK, Joshi K, Shinde V, Rakshit S, Biswas N, et al. Hydroxychavicol, a piper betle leaf component, induces apoptosis of CML cells through mitochondrial reactive oxygen species-dependent JNK and endothelial nitric oxide synthase activation and overrides imatinib resistance. Cancer Sci 2012;103:88–99.
Sugapriya D, Shanthi P, Sachdanandam P. Restoration of energy metabolism in leukemic mice treated by a Siddha drug—Semecarpus anacardium Linn. nut milk extract. Chem Biol Interact 2008;173:43–58.
Mythilypriya R, Shanthi P, Sachdanandam P. Oral acute and subacute toxicity studies with Kalpaamruthaa, a modifi ed indigenous preparation on animals. J Health Sci 2007;53:354–358.
Mythilypriya R, Shanthi P, Sachdanandam P. Therapeutic effect of Kalpaamruthaa, a herbal preparation on adjuvant induced arthritis in wistar animals. Infl ammopharmacology 2008;16:21–35.
Mythilypriya R, Shanthi P, Sachdanandam P. Restorative and synergistic efficacy of Kalpaamruthaa, a modified Siddha preparation, on an altered antioxidant status in adjuvant induced arthritic rat model. Chem Biol Interact 2007;168:193–202.
Veena K, Shanthi P, Sachdanandam P. Anticancer effect of Kalpaamruthaa onmammary carcinoma in animals with reference to glycoprotein components, lysosomal and marker enzymes. Biol Pharm Bull 2006;29:565–569.
Shanthi P, Sugapriya D, Haseena BHK, Sachdanandam P. Antileukemic effect of Kalpaamruthaa, a modified Siddha preparation, in BCR-ABL+ cell line induced chronic myeloid leukemic mouse model. Comp Clin Pathol 2014;23:653–664.
Formulary of Siddha medicine. 2nd ed. Madras: Indian Medicine Practitioners Co-operative Pharmacy and Stores; 1972:197.
McLaughlin J, Chianese E, Witte ON. In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome. Proc Natl Acad Sci USA 1987;84:6558–6562.
He L, Feng H, Raymond A, Kreeger M, Zeng Y, Graner M, et al. Dendritic-cell-peptide immunization provides immunoprotection against BCR-ABL positive leukemia in mice. Cancer Immunol Immunother 2001;50:31–40.
Zeng Y, Graner MW, Feng H, Li G, Katsanis E. Imatinib mesylate effectively combines with chaperone-rich cell lysate loaded dendritic cells to treat bcr-abl-murine leukemia. Int J Cancer 2004;110:251–259.
Senior AE, McGowan SE, Hilf R. A comparative study of inner membrane enzymes and transport systems in mitochondria from R3230AC mammary tumor and normal rat mammary gland. Cancer Res 1975;35:2061–2067.
Slater EC, Bonner WD. Inhibition of the succinic oxidase system by fl uoride. Biochem J 1951;4:185–196.
Lowry OH, Rosebrough NJ, Farr AL, Randall AJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265–275.
Branstrup N, Krik JE, Bruni CJ. The hexokinase and phosphoglucoisomerase activities of aorta and pulmonary artery tissue in individuals of various ages. Gerontology 1957;12:166–171.
King J. Practical and clinical enzymology. London: The Transferases Alanine and Aspartate Transaminases D. Van Nostrand Co. Ltd.; 1975:121–138.
King J. Practical and clinical enzymology. London: The Phosphohydrolases Acid and Alkaline Phosphatases. D. Van Nostrand Co. Ltd.; 1965:191–208.
Gancedo JM, Gancedo C. Fructose-1-6-bisphosphatase, phosphofructokinase and glucose-6-phosphate dehydrogenase. Proc Soc Exp Biol Med 1972;106:607–609.
Bernt E, Bergmeyer HV. Methods of enzymatic analysis. New York: Academic Press; 1974.
Reed LJ, Mukherjee RB. A ketoglutarate dehydrogenase complex from Escherichia coli. Methods Enzymol 1969;13:55–61.
Mehler AH, Kornberg A, Grisolia S, Ochoa S. The enzymatic mechanism of oxidation-reductions between malate or isocitrate and pyruvate. J Biol Chem 1948;714:961–977.
Minakami S, Ringer RL, Singer TP. The enzymatic mechanism of oxidation±reductions between malate or isocitrate and pyruvate. J Biol Chem 1962;237:569–576.
Wharton DC, Tzagoloff A. Cytochrome oxidase from beef heart mitochondria. Methods Enzymol 1967;10:245–250.
Yin X, Zhou J, Jie C, Xing D, Zhang Y. Anticancer activity and mechanism of Scutellaria barbata extract on human lung cancer cell line A549. Life Sci 2004;75:2233–2244.
Mahady G. Global harmonisation of herbal health claims. Journal of Nutrition 2001;131:162–196.
Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer 2011;11:85–95.
Warburg O. On the origin of cancer cells. Science 1956;123:309–314.
Lunt SY, Vander Heiden MG. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol 2011;27:441–464.
Klawitter J, Kominsky DJ, Brown J, Klawitter J, Christians U, Leibfritz D, et al. Metabolic characteristics of imatinib resistance in chronic myeloid leukaemia cells. Br J Pharmacol 2009;158:588–600.
Suolinna M, Buchsbaum RN, Racker E. The effect of fl avonoids and aerobic glycolysis and growth of tumor cells. Cancer Res 1975;35:1865–1872.
Arathi G, Sachdanandam P. Therapeutic effect of Semecarpus anacardium Linn. nut milk extract on carbohydrate metabolizing and mitochondrial TCA cycle and respiratory chain enzymes in mammary carcinoma animals. J Pharm Pharmacol 2003;55:1283–1290.
Sattler M, Verma S, Shrikhande G, Byrne CH, Pride YB. The BCR/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells. J Biol Che 2000;275:24273–2427.
Shoffner JM, Wallace DC. Oxidative phosphorylation diseases and mitochondrial DNA mutations: diagnosis and treatment. Annu Rev Nutr 1994;14:535–568.
Pederson PL. Tumor mitochondria and the bioenergetics of cancer cells. Prog Exp Tumor Res 1978;22:190–274.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Palanivelu, S., Dhanasekeran, S., Khan, H.B.H. et al. Ameliorating effect of Kalpaamruthaa on altered energy metabolism in BCR-ABL+ cell line induced leukemic mouse model. Chin. J. Integr. Med. (2016). https://doi.org/10.1007/s11655-015-2283-2
Received:
Published:
DOI: https://doi.org/10.1007/s11655-015-2283-2